Weight Management
The science of GLP-1 medications, metabolic health, and body composition.
20 peer-reviewed studies indexed
What the Research Says
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
Variable Effects of Glucagon Like Peptide-1 Receptor Agonists on Body Composition in Older Women
Semaglutide vs tirzepatide in patients with obesity and HFpEF: a report from a global federated research network.
Use of Tirzepatida (Mounjaro) as a Therapeutic Agent in Obesity and Type 2 Diabetes: A Systematic Review on Metabolic Control with GLP-1 Agonists
Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series
Distinct effects of semaglutide and tirzepatide on metabolic and inflammatory gene expression in brown adipose tissue of mice fed a high-fat, high-fructose diet
In adults with obesity but without type 2 diabetes, tirzepatide increased weight loss at 72 wk compared with semaglutide.
Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison.
Weight loss in people with type 1 diabetes over 12 months: Real-world data comparing tirzepatide, semaglutide and liraglutide.
Dietary Modulation and Clinical Outcomes During GLP-1 Receptor Agonist Therapy. A Literature Review
Early Dose Escalation of Tirzepatide after Switching from Semaglutide in Type 2 Diabetes Mellitus.
Taking back control: The experience of adults using semaglutide and tirzepatide for obesity treatment - A qualitative study.
Efficacy and Safety of Tirzepatide and Semaglutide for Obesity Management: A Real-World Comparison.
The Dual-Agonist Advantage: Comparing Tirzepatide (GIP/GLP-1) Efficacy Against Single GLP-1 RAs (Semaglutide) in T2DM
Short-Term Effects of Tirzepatide in Obese Adults: A Real-World Prospective Study.
Obesity update: cardiovascular risk and therapeutic innovations (focus on semaglutide and tirzepatide).
Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence
A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass
127-OR: The Effect of Tirzepatide during Weight Loss on Metabolic Adaption, Fat Oxidation, and Food Intake in People with Obesity
Real-World Weight-Loss Outcomes in Weight-Reduced Patients Treated With Tirzepatide.
Want to see if this applies to you?
Upload your bloodwork and we'll cross-reference your results against these studies.
Upload Your Labs for Free